This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Chronic Bronchiolitis or Resistant Asthma?

This study has been completed.
Information provided by:
Baqiyatallah Medical Sciences University Identifier:
First received: August 22, 2006
Last updated: February 17, 2009
Last verified: January 2006
Chronic Bronchiolitis or Resistant Asthma? Testing a way to diagnosis and treatment

Condition Intervention Phase
Asthma Drug: Erythromycin, Azithromycin , Clarithromycin Phase 4

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment

Resource links provided by NLM:

Further study details as provided by Baqiyatallah Medical Sciences University:


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All

Inclusion Criteria:

  • Difficult asthma

Exclusion Criteria:

  • Patients with potential allergic bronchopulmonary aspergillosis i.e. with peripheral blood eosinophilia, sputum eosinophilia, or any sputum production and bronchiectasis
  • A history of smoking
  • Significant occupational or environmental exposures
  • Evidence on emphysema on chest high resolution computed tomography (HRCT) scan
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00368342

Sponsors and Collaborators
Baqiyatallah Medical Sciences University
Principal Investigator: Mostafa Ghanei, Prof Research Center of Chemical Injuries, Baqyatallah Medical Sciences University, Tehran, Iran
  More Information Identifier: NCT00368342     History of Changes
Other Study ID Numbers: S-340-14-6-1-PU-79
Study First Received: August 22, 2006
Last Updated: February 17, 2009

Additional relevant MeSH terms:
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases
Erythromycin Estolate
Erythromycin Ethylsuccinate
Erythromycin stearate
Anti-Bacterial Agents
Anti-Infective Agents
Protein Synthesis Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Cytochrome P-450 CYP3A Inhibitors
Cytochrome P-450 Enzyme Inhibitors
Gastrointestinal Agents processed this record on September 21, 2017